Reduced size of sebaceous gland and altered sebum lipid composition in mice lacking fatty acid binding protein 5 gene

Experimental Dermatology

Volumn 21, Issue 7, 2012, Pages 543-546

  Sugawara, Tomoko ^a   Nemoto, Kei ^b,c   Adachi, Yasuhiro ^b   Yamano, Nozomi ^b   Tokuda, Nobuko ^b   Muto, Masahiko ^b   Okuyama, Ryuhei ^c   Sakai, Shingo ^a   Owada, Yuji ^b  

^a KANEBO LTD   (Japan)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

FABP5; Maturation; Sebaceous gland; Sebocyte

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CELLULAR RETINOIC ACID BINDING PROTEIN 2; CHOLESTEROL ESTER; FAT DROPLET; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; FATTY ALCOHOL; KI 67 ANTIGEN; MYC PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; EPIDERMIS; HAIR FOLLICLE; LETTER; LIPID COMPOSITION; LIPID METABOLISM; LIPOGENESIS; MOUSE; NONHUMAN; ORGAN SIZE; PROTEIN EXPRESSION; SEBACEOUS GLAND; SEBUM; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; FATTY ACID-BINDING PROTEINS; KI-67 ANTIGEN; LIPIDS; MICE; NEOPLASM PROTEINS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, RETINOIC ACID; SEBACEOUS GLANDS; SEBUM; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84863113696     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01514.x     Document Type: Letter

References (20)

1. Nakatsuji T, Kao M C, Zhang L et al. J Invest Dermatol 2010: 130: 985-994.
2. Makrantonaki E, Ganceviciene R, Zouboulis C. Dermatoendocrinol 2011: 3: 41-49.
3. Kurokawa I, Danby F W, Ju Q et al. Exp Dermatol 2009: 18: 821-832.
4. Thiboutot D. J Invest Dermatol 2004: 123: 1-12.
5. Toth B I, Olah A, Szollosi A G, Czifra G, Biro T. Pflugers Arch 2011: 461: 593-606.
6. Tan N S, Shaw N S, Vinckenbosch N et al. Mol Cell Biol 2002: 22: 5114-5127.
7. Glatz J F, van der Vusse G J. Prog Lipid Res 1996: 35: 243-282.
8. Kusakari Y, Ogawa E, Owada Y et al. Mol Cell Biochem 2006: 284: 183-188.
9. Watanabe R, Fujii H, Yamamoto A et al. J Dermatol Sci 1997: 16: 17-22.
10. Owada Y, Takano H, Yamanaka H et al. J Invest Dermatol 2002: 118: 430-435.
11. Ogawa E, Owada Y, Ikawa S et al. J Invest Dermatol 2011: 131: 604-612.
12. Ito M, Suzuki M, Motoyoshi K, Maruyama T, Sato Y. J Invest Dermatol 1984: 82: 381-385.
13. Horsley V, O'Carroll D, Tooze R et al. Cell 2006: 126: 597-609.
14. Lo Celso C, Berta M A, Braun K M et al. Stem Cells 2008: 26: 1241-1252.
15. Downie M M, Sanders D A, Maier L M, Stock D M, Kealey T. Br J Dermatol 2004: 151: 766-775.
16. Trivedi N R, Cong Z, Nelson A M et al. J Invest Dermatol 2006: 126: 2002-2009.
17. Everts H B, Sundberg J P, King L E Jr, Ong D E. J Invest Dermatol 2007: 127: 1593-1604.
18. Collins C A, Watt F M. Dev Biol 2008: 324: 55-67.
19. Tsukada M, Schroder M, Roos T C et al. J Invest Dermatol 2000: 115: 321-327.
20. Schug T T, Berry D C, Shaw N S, Travis S N, Noy N. Cell 2007: 129: 723-733.